scholarly article | Q13442814 |
P819 | ADS bibcode | 2001PNAS...98..259P |
P356 | DOI | 10.1073/PNAS.011481398 |
10.1073/PNAS.98.1.259 | ||
P932 | PMC publication ID | 14578 |
P698 | PubMed publication ID | 11134514 |
P2093 | author name string | N. C. Andrews | |
J. E. Levy | |||
L. K. Jackson | |||
K. R. Thomas | |||
J. D. Phillips | |||
M. R. Franklin | |||
M. Bunting | |||
J. P. Kushner | |||
P2860 | cites work | Cytochrome P450 Induction, Uroporphyrinogen Decarboxylase Depression, Porphyrin Accumulation and Excretion, and Gender Influence in a 3-Week Rat Model of Porphyria Cutanea Tarda | Q50912329 |
Analysis of uroporphyrinogen decarboxylase complementary DNAs in sporadic porphyria cutanea tarda | Q72222361 | ||
Disease-related conditions in relatives of patients with hemochromatosis | Q73214130 | ||
Hemochromatosis genes and other factors contributing to the pathogenesis of porphyria cutanea tarda | Q73479476 | ||
Porphyria cutanea tarda | Q74359781 | ||
Cutaneous Porphyria in Turkey | Q78906790 | ||
Crystal structure of human uroporphyrinogen decarboxylase | Q24533224 | ||
Familial Porphyria Cutanea Tarda: Characterization of Seven Novel Uroporphyrinogen Decarboxylase Mutations and Frequency of Common Hemochromatosis Alleles | Q24539508 | ||
Uroporphyrinogen decarboxylase: a splice site mutation causes the deletion of exon 6 in multiple families with porphyria cutanea tarda | Q24618277 | ||
High-fidelity gene targeting in embryonic stem cells by using sequence replacement vectors | Q24630186 | ||
Uroporphyrinogen decarboxylase: complete human gene sequence and molecular study of three families with hepatoerythropoietic porphyria | Q24676183 | ||
Characterization of a new mutation (R292G) and a deletion at the human uroporphyrinogen decarboxylase locus in two patients with hepatoerythropoietic porphyria | Q28118865 | ||
The C282Y mutation causing hereditary hemochromatosis does not produce a null allele | Q28138010 | ||
Screening for mutations in the uroporphyrinogen decarboxylase gene using denaturing gradient gel electrophoresis. Identification and characterization of six novel mutations associated with familial PCT | Q28143875 | ||
Three new mutations in the uroporphyrinogen decarboxylase gene in familial porphyria cutanea tarda. Mutation in brief no. 237. Online | Q28144490 | ||
Molecular defects of uroporphyrinogen decarboxylase in a patient with mild hepatoerythropoietic porphyria | Q28253068 | ||
HFE gene knockout produces mouse model of hereditary hemochromatosis | Q28263309 | ||
A point mutation in the coding region of uroporphyrinogen decarboxylase associated with familial porphyria cutanea tarda | Q28284565 | ||
Molecular cloning and nucleotide sequence of a complete human uroporphyrinogen decarboxylase cDNA | Q28287563 | ||
Identification of a new mutation responsible for hepatoerythropoietic porphyria | Q28302834 | ||
Uroporphyrinogen decarboxylase structural mutant (Gly281----Glu) in a case of porphyria | Q28304563 | ||
Mouse uroporphyrinogen decarboxylase: cDNA cloning, expression, and mapping | Q28590365 | ||
Purification and properties of uroporphyrinogen decarboxylase from human erythrocytes. A single enzyme catalyzing the four sequential decarboxylations of uroporphyrinogens I and III | Q28678700 | ||
Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes | Q29547355 | ||
Derivation of completely cell culture-derived mice from early-passage embryonic stem cells | Q29547491 | ||
Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells | Q29614545 | ||
Isolation and identification of a cDNA clone coding for rat uroporphyrinogen decarboxylase | Q36268782 | ||
Characterization and crystallization of human uroporphyrinogen decarboxylase | Q36280407 | ||
Macrocyclic intermediates in the biosynthesis of porphyrins | Q39091572 | ||
Genetic variation of iron-induced uroporphyria in mice | Q41969993 | ||
Order of uroporphyrinogen III decarboxylation on incubation of porphobilinogen and uroporphyrinogen III with erythrocyte uroporphyrinogen decarboxylase | Q42067146 | ||
Uroporphyrinogen decarboxylase in Saccharomyces cerevisiae. HEM12 gene sequence and evidence for two conserved glycines essential for enzymatic activity | Q42610675 | ||
Porphyria cutanea tarda, hepatitis C, and HFE gene mutations in north america† | Q42988426 | ||
Immunoreactive uroporphyrinogen decarboxylase in the liver in porphyria cutanea tarda | Q44872150 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | porphyria cutanea tarda | Q1479497 |
Uroporphyrinogen decarboxylase | Q14888129 | ||
P304 | page(s) | 259–264 | |
P577 | publication date | 2001-01-02 | |
P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
P1476 | title | A mouse model of familial porphyria cutanea tarda | |
P478 | volume | 98 |
Q33228017 | A knock-in mouse model of congenital erythropoietic porphyria. |
Q30487121 | A mouse chromosome 4 balancer ENU-mutagenesis screen isolates eleven lethal lines. |
Q24681370 | A porphomethene inhibitor of uroporphyrinogen decarboxylase causes porphyria cutanea tarda |
Q42164539 | Accelerated development of uroporphyria in mice heterozygous for a deletion at the uroporphyrinogen decarboxylase locus |
Q84587889 | Attenuation of polychlorinated biphenyl induced uroporphyria by iron deprivation |
Q29620380 | Balancing acts: molecular control of mammalian iron metabolism |
Q45891191 | Co-existence of hereditary coproporphyria and porphyria cutanea tarda: The importance of genetic testing |
Q35220569 | Dietary iron controls circadian hepatic glucose metabolism through heme synthesis |
Q37002005 | Down-regulation of hepcidin in porphyria cutanea tarda |
Q27636360 | Functional consequences of naturally occurring mutations in human uroporphyrinogen decarboxylase |
Q45070103 | Genetic factors influence ethanol-induced uroporphyria in Hfe(-/-) mice |
Q38216392 | Heme and erythropoieis: more than a structural role. |
Q92046226 | Heme biosynthesis and the porphyrias |
Q30857134 | Identification of a mutation in the ovine uroporphyrinogen decarboxylase (UROD) gene associated with a type of porphyria |
Q36459893 | Iron in skin of mice with three etiologies of systemic iron overload. |
Q35539189 | Mass-spectrometric profiling of porphyrins in complex biological samples with fundamental, toxicological, and pharmacological applications |
Q91428291 | Murine models of the human porphyrias: Contributions toward understanding disease pathogenesis and the development of new therapies |
Q40993097 | Porphyria cutanea tara |
Q37801101 | Porphyria cutanea tarda – When skin meets liver |
Q79449871 | Porphyria cutanea tarda: a possible role for ascorbic acid |
Q39189271 | Porphyria cutanea tarda: an intriguing genetic disease and marker |
Q92986782 | Porphyrin-Induced Protein Oxidation and Aggregation as a Mechanism of Porphyria-Associated Cell Injury |
Q27642606 | Structural basis for tetrapyrrole coordination by uroporphyrinogen decarboxylase |
Q27654683 | Substrate Shuttling between Active Sites of Uroporphyrinogen Decarboxylase Is Not Required to Generate Coproporphyrinogen |
Q35029978 | Targeted deletion of the mouse Mitoferrin1 gene: from anemia to protoporphyria. |
Q36747020 | Transgenic Leishmania model for delta-aminolevulinate-inducible monospecific uroporphyria: cytolytic phototoxicity initiated by singlet oxygen-mediated inactivation of proteins and its ablation by endosomal mobilization of cytosolic uroporphyrin |
Q27643599 | Two novel uroporphyrinogen decarboxylase (URO-D) mutations causing hepatoerythropoietic porphyria (HEP) |
Q42519264 | Uroporphyria in mice: thresholds for hepatic CYP1A2 and iron |
Q39345761 | Uroporphyria in the Cyp1a2-/- mouse |
Q28485387 | Uroporphyrinogen Decarboxylase as a Potential Target for Specific Components of Traditional Chinese Medicine: A Virtual Screening and Molecular Dynamics Study |
Q34507288 | Uroporphyrinogen III synthase knock-in mice have the human congenital erythropoietic porphyria phenotype, including the characteristic light-induced cutaneous lesions |
Search more.